Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 40,579 | 8,308 | 9,636 | 12,740 | 1 |
| Cost of Goods | 1,356 | 0 | N/A | N/A | N/A |
| Gross Profit | 39,223 | 8,308 | 9,636 | 12,740 | 1 |
| Operating Expenses | 163,064 | 104,579 | 70,748 | 50,630 | 24,578 |
| Operating Income | -123,485 | -96,271 | -61,112 | -37,890 | -24,577 |
| Interest Expense | 13,932 | 11,362 | 5,296 | 4,838 | 0 |
| Other Income | 103,387 | 0 | 3,691 | -3,363 | 375 |
| Pre-tax Income | -34,030 | -107,633 | -62,717 | -46,091 | -24,202 |
| Income Tax | N/A | N/A | N/A | 20 | 212 |
| Net Income Continuous | -34,030 | -107,633 | -62,717 | -46,111 | -24,414 |
| Net Income | $-34,030 | $-107,633 | $-62,717 | $-46,111 | $-24,414 |
| EPS Basic Total Ops | -1.77 | -6.73 | -5.04 | -3.94 | -3.12 |
| EPS Basic Continuous Ops | -1.77 | -6.73 | -5.04 | -3.94 | -3.12 |
| EPS Diluted Total Ops | -1.77 | -6.73 | -5.04 | -3.94 | -3.12 |
| EPS Diluted Continuous Ops | -1.77 | -6.73 | -5.04 | -3.94 | -3.12 |
| EPS Diluted Before Non-Recurring Items | -5.93 | -6.73 | -5.04 | -3.94 | -3.15 |
| EBITDA(a) | $-110,300 | $-85,053 | $-52,625 | $-37,845 | $-24,379 |